MedMen Completes Sale of Florida Assets
Ryan Allway August 22nd, 2022 News, Top News Company considering strategic alternatives for New York’s adult-use market. LOS ANGELES, August 22, 2022–(BUSINESS WIRE)–MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis retailer with operations across the United States, today announced the close of a... Read more
Skye Bioscience Reports that Emerald Health Therapeutics Shareholders Voted in Favor of Plan of Arrangement with Skye
San Diego, California, August 19, 2022 — Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, reports that the shareholders of Emerald Health Therapeutics, Inc. (“Emerald” or the “Company”) (CSE: EMH; OTCQB: EMHTF) today approved the proposed plan of arrangement... Read more
Unrivaled Brands Reports Second Quarter 2022 Financial Results
Ryan Allway August 19th, 2022 News, Top News SANTA ANA, Calif., Aug. 19, 2022 (GLOBE NEWSWIRE) — Unrivaled Brands, Inc. (OTCQX: UNRV) (“Unrivaled” or the “Company”), a multi-state vertically integrated company focused on the cannabis sector with operations in California and Oregon, yesterday reported its second quarter 2022 financial... Read more
Decibel Announces Second Quarter Results with Another Period of Record Net Revenue and Adjusted EBITDA
Ryan Allway August 18th, 2022 News, Top News CALGARY, AB, Aug. 18, 2022 /PRNewswire/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSX-V: DB) (OTCQB: DBCCF), a premium cannabis producer, is pleased to announce its second quarter financial results for the three and six month periods ending June 30, 2022. Decibel... Read more
CBD Life Sciences, Inc. (CBDL) Distributes NEW Infused Gummies Nationwide
Ryan Allway August 18th, 2022 News, Top News SCOTTSDALE, AZ / ACCESSWIRE / August 18, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company is taking an innovative approach by introducing a product that is infused with both... Read more
Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 Second Quarter Financial and Operational Results
Ryan Allway August 18th, 2022 News, Top News SAN DIEGO, CA, Aug. 18, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced its financial... Read more
Grapefruit USA, Inc. Provides Update on Diagnostic Lab Corporation, Inc. Acquisition, Secures New Financing
Ryan Allway August 18th, 2022 News, Top News LOS ANGELES and DESERT HOT SPRINGS, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based cannabiotech company, today updates its recent announcement of the proposed acquisition of Diagnostic... Read more
BioHarvest Sciences Inc. Launches First Major United States Marketing Campaign
Ryan Allway August 18th, 2022 News, Top News Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – August 18, 2022) – BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”) has announced the first multimedia campaign for VINIA™ in the USA, Phase 1. The company is scaling up... Read more
High Tide Secures Commitment Letter from Connect First Credit Union for Non-Dilutive Financing
Ryan Allway August 18th, 2022 News, Top News CALGARY, August 18, 2022 /CNW/ – High Tide Inc. (“High Tide” or the “Company”) (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets, announced today that it has entered into a... Read more
PharmAla Biotech Becomes First Publicly Traded Company to Produce GMP MDMA
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )